Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page gains new user-guidance sections and a renamed Intervention/Treatment area, while also showing that recruitment is closed and noting a page revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:08:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4. This reflects a site update rather than any change to the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-06-07T01:39:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears on the page, updating the site version label. The previous label Revision: v3.5.3 has been removed.
    Difference
    0.0%
    Check dated 2026-05-16T10:50:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T22:42:50.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:19:25.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T00:17:56.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.